In: Molecular Medicine, 2020, vol. 26, no. 1, p. 102
Clinical observations and preclinical studies both suggest that Down syndrome (DS) may be associated with significant metabolic and bioenergetic alterations. However, the relevant scientific literature has not yet been systematically reviewed. The aim of the current study was to conduct a meta-analysis of metabolites involved in bioenergetics pathways in DS to conclusively determine the...
|
In: Analytical and Bioanalytical Chemistry, 2014, vol. 406, no. 11, p. 2627-2640
|
In: Intensive Care Medicine, 2014, vol. 40, no. 4, p. 623-624
|
In: Clinical Chemistry and Laboratory Medicine (CCLM), 2016, vol. 54, no. 4, p. 617-625
|
In: Metabolomics, 2014, vol. 10, no. 2, p. 291-301
|
In: Journal of The American Society for Mass Spectrometry, 2014, vol. 25, no. 7, p. 1263-1273
|
In: Metabolomics, 2009, vol. 5, no. 2, p. 209-218
|
In: International Journal of Pancreatology, 1999, vol. 25, no. 1, p. 65-68
|
In: Analytical and Bioanalytical Chemistry, 2012, vol. 404, no. 6-7, p. 1831-1838
|
In: Analytical and Bioanalytical Chemistry, 2010, vol. 398, no. 6, p. 2493-2504
|